high complete remission rate Latest Research Papers

R-CHOP/R-HDAC AND RITUXIMAB MAINTENANCE RESULTS IN HIGH COMPLETE REMISSION RATE, MINIMAL RESIDUAL DISEASE NEGATIVITY, AND EXCELLENT SURVIVAL IN ELDERLY MCL PATIENTS

Hematological Oncology ◽

10.1002/hon.2438_68 ◽

2017 ◽

Vol 35 ◽

pp. 204-205

Author(s):

P. Klener ◽

E. Fronkova ◽

D. Belada ◽

K. Forsterova ◽

R. Pytlik ◽

...

Keyword(s):

Complete Remission ◽

Minimal Residual Disease ◽

Residual Disease ◽

Remission Rate ◽

Complete Remission Rate ◽

Rituximab Maintenance ◽

Minimal Residual ◽

High Complete Remission Rate

Download Full-text

Faculty Opinions recommendation of First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725304668.793527320 ◽

2017 ◽

Author(s):

Aimee Payne

Keyword(s):

Complete Remission ◽

Combination Therapy ◽

Bullous Pemphigoid ◽

Remission Rate ◽

Complete Remission Rate ◽

First Line ◽

High Complete Remission Rate

Download Full-text

First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid

British Journal of Dermatology ◽

10.1111/bjd.13633 ◽

2015 ◽

Vol 173 (1) ◽

pp. 302-304 ◽

Cited By ~ 35

Author(s):

Y.T. Cho ◽

C.Y. Chu ◽

L.F. Wang

Keyword(s):

Complete Remission ◽

Combination Therapy ◽

Bullous Pemphigoid ◽

Remission Rate ◽

Complete Remission Rate ◽

First Line ◽

High Complete Remission Rate

Download Full-text

High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma

Clinical Transplantation ◽

10.1111/j.1399-0012.2008.00950.x ◽

2009 ◽

Vol 23 (6) ◽

pp. 839-847 ◽

Cited By ~ 1

Author(s):

Basak Oyan ◽

Yener Koc ◽

Evren Ozdemir ◽

Ayse Kars ◽

Alev Turker ◽

...

Keyword(s):

Multiple Myeloma ◽

Stem Cell ◽

Complete Remission ◽

Stem Cell Transplantation ◽

Cell Transplantation ◽

Autologous Stem Cell Transplantation ◽

Remission Rate ◽

Allogeneic Transplantation ◽

Complete Remission Rate ◽

High Complete Remission Rate

Download Full-text

Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia

Leukemia ◽

10.1038/sj.leu.2404287 ◽

2006 ◽

Vol 20 (8) ◽

pp. 1361-1367 ◽

Cited By ~ 51

Author(s):

J Jin ◽

D-Z Jiang ◽

W-Y Mai ◽

H-T Meng ◽

W-B Qian ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Complete Remission ◽

Induction Therapy ◽

Myeloid Leukemia ◽

De Novo ◽

Remission Rate ◽

Complete Remission Rate ◽

Acute Myeloid ◽

High Complete Remission Rate

Download Full-text

High Complete Remission Rate in Hairy Cell Leukemia Treated with 2-Chlorodeoxyadenosine

Leukemia & Lymphoma ◽

10.3109/10428199309067932 ◽

1993 ◽

Vol 11 (5-6) ◽

pp. 399-404 ◽

Cited By ~ 10

Author(s):

F. Lauria ◽

D. Benfenati ◽

D. Raspadori ◽

D. Rondelli ◽

P. L. Zinzani ◽

...

Keyword(s):

Complete Remission ◽

Hairy Cell Leukemia ◽

Remission Rate ◽

Complete Remission Rate ◽

Hairy Cell ◽

Cell Leukemia ◽

High Complete Remission Rate

Download Full-text

high complete remission rate
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

R-CHOP/R-HDAC AND RITUXIMAB MAINTENANCE RESULTS IN HIGH COMPLETE REMISSION RATE, MINIMAL RESIDUAL DISEASE NEGATIVITY, AND EXCELLENT SURVIVAL IN ELDERLY MCL PATIENTS

Faculty Opinions recommendation of First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid.

First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid

High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma

Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia

High Complete Remission Rate in Hairy Cell Leukemia Treated with 2-Chlorodeoxyadenosine

Export Citation Format

high complete remission rateRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

R-CHOP/R-HDAC AND RITUXIMAB MAINTENANCE RESULTS IN HIGH COMPLETE REMISSION RATE, MINIMAL RESIDUAL DISEASE NEGATIVITY, AND EXCELLENT SURVIVAL IN ELDERLY MCL PATIENTS

Faculty Opinions recommendation of First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid.

First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid

High complete remission rate and durable remissions achieved with rational use of autologous stem-cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma

Homoharringtonine in combination with cytarabine and aclarubicin resulted in high complete remission rate after the first induction therapy in patients with de novo acute myeloid leukemia

High Complete Remission Rate in Hairy Cell Leukemia Treated with 2-Chlorodeoxyadenosine

high complete remission rate
Recently Published Documents